These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23553751)

  • 1. Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (Copd); implications for stratified medicine?
    Natanek SA; Gosker HR; Slot IG; Marsh GS; Hopkinson NS; Man WD; Tal-Singer R; Moxham J; Kemp PR; Schols AM; Polkey MI
    Muscle Nerve; 2013 Oct; 48(4):488-97. PubMed ID: 23553751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD.
    van den Borst B; Slot IG; Hellwig VA; Vosse BA; Kelders MC; Barreiro E; Schols AM; Gosker HR
    J Appl Physiol (1985); 2013 May; 114(9):1319-28. PubMed ID: 22815389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MuRF-1 and atrogin-1 protein expression and quadriceps fiber size and muscle mass in stable patients with COPD.
    Natanek SA; Riddoch-Contreras J; Marsh GS; Hopkinson NS; Moxham J; Man WD; Kemp PR; Polkey MI
    COPD; 2013 Oct; 10(5):618-24. PubMed ID: 23844868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in COPD-related quadriceps muscle dysfunction and fibre abnormalities.
    Sharanya A; Ciano M; Withana S; Kemp PR; Polkey MI; Sathyapala SA
    Chron Respir Dis; 2019; 16():1479973119843650. PubMed ID: 31131626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failed upregulation of TFAM protein and mitochondrial DNA in oxidatively deficient fibers of chronic obstructive pulmonary disease locomotor muscle.
    Konokhova Y; Spendiff S; Jagoe RT; Aare S; Kapchinsky S; MacMillan NJ; Rozakis P; Picard M; Aubertin-Leheudre M; Pion CH; Bourbeau J; Hepple RT; Taivassalo T
    Skelet Muscle; 2016; 6():10. PubMed ID: 26893822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways associated with reduced quadriceps oxidative fibres and endurance in COPD.
    Natanek SA; Gosker HR; Slot IG; Marsh GS; Hopkinson NS; Moxham J; Kemp PR; Schols AM; Polkey MI
    Eur Respir J; 2013 Jun; 41(6):1275-83. PubMed ID: 23258787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in micro-RNA expression profile between vastus lateralis samples and myotubes in COPD cachexia.
    Barreiro E; Sancho-Muñoz A; Puig-Vilanova E; Salazar-Degracia A; Pascual-Guardia S; Casadevall C; Gea J
    J Appl Physiol (1985); 2019 Feb; 126(2):403-412. PubMed ID: 30543501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle adiposity is associated with physical activity, exercise capacity and fibre shift in COPD.
    Maddocks M; Shrikrishna D; Vitoriano S; Natanek SA; Tanner RJ; Hart N; Kemp PR; Moxham J; Polkey MI; Hopkinson NS
    Eur Respir J; 2014 Nov; 44(5):1188-98. PubMed ID: 24993908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in function and structure of the quadriceps muscle in chronic obstructive pulmonary disease patients.
    Ausín P; Martínez-Llorens J; Sabaté-Bresco M; Casadevall C; Barreiro E; Gea J
    Chron Respir Dis; 2017 May; 14(2):127-139. PubMed ID: 27923983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with impairment of quadriceps muscle function in Chinese patients with chronic obstructive pulmonary disease.
    Ju C; Chen R
    PLoS One; 2014; 9(2):e84167. PubMed ID: 24558357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fiber atrophy, oxidative stress, and oxidative fiber reduction are the attributes of different phenotypes in chronic obstructive pulmonary disease patients.
    Gouzi F; Abdellaoui A; Molinari N; Pinot E; Ayoub B; Laoudj-Chenivesse D; Cristol JP; Mercier J; Hayot M; Préfaut C
    J Appl Physiol (1985); 2013 Dec; 115(12):1796-805. PubMed ID: 24136107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of endurance versus resistance training on quadriceps muscle dysfunction in COPD: a pilot study.
    Iepsen UW; Munch GD; Rugbjerg M; Rinnov AR; Zacho M; Mortensen SP; Secher NH; Ringbaek T; Pedersen BK; Hellsten Y; Lange P; Thaning P
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2659-2669. PubMed ID: 27822028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnosine, oxidative and carbonyl stress, antioxidants, and muscle fiber characteristics of quadriceps muscle of patients with COPD.
    De Brandt J; Burtin C; Pomiès P; Vandenabeele F; Verboven K; Aumann J; Blancquaert L; Everaert I; Van Ryckeghem L; Cops J; Hayot M; Spruit MA; Derave W
    J Appl Physiol (1985); 2021 Oct; 131(4):1230-1240. PubMed ID: 34323590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD.
    Seymour JM; Ward K; Sidhu PS; Puthucheary Z; Steier J; Jolley CJ; Rafferty G; Polkey MI; Moxham J
    Thorax; 2009 May; 64(5):418-23. PubMed ID: 19158125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction in airways and quadriceps muscle of patients with chronic obstructive pulmonary disease.
    Haji G; Wiegman CH; Michaeloudes C; Patel MS; Curtis K; Bhavsar P; Polkey MI; Adcock IM; Chung KF;
    Respir Res; 2020 Oct; 21(1):262. PubMed ID: 33046036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle Quality is More Impaired in Sarcopenic Patients With Chronic Obstructive Pulmonary Disease.
    van de Bool C; Gosker HR; van den Borst B; Op den Kamp CM; Slot IG; Schols AM
    J Am Med Dir Assoc; 2016 May; 17(5):415-20. PubMed ID: 26848065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiorespiratory and Muscle Oxygenation Responses to Isokinetic Exercise in Chronic Obstructive Pulmonary Disease.
    Ribeiro F; Oueslati F; Saey D; Lépine PA; Chambah S; Coats V; Maltais F
    Med Sci Sports Exerc; 2019 May; 51(5):841-849. PubMed ID: 30531487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of quadriceps muscle weakness in patients with COPD and its association with disease severity.
    Kharbanda S; Ramakrishna A; Krishnan S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1727-35. PubMed ID: 26366065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD.
    Shrikrishna D; Tanner RJ; Lee JY; Natanek A; Lewis A; Murphy PB; Hart N; Moxham J; Montgomery HE; Kemp PR; Polkey MI; Hopkinson NS
    Chest; 2014 Oct; 146(4):932-940. PubMed ID: 24556825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of the quadriceps strength in patients with chronic obstructive pulmonary disease].
    Ju CR; Chen RC
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Aug; 31(8):566-70. PubMed ID: 19080397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.